These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 29239213

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Field-testing of the ICHD-3 beta/proposed ICD-11 diagnostic criteria for migraine with aura.
    Li D, Christensen AF, Olesen J.
    Cephalalgia; 2015 Aug; 35(9):748-56. PubMed ID: 25424707
    [Abstract] [Full Text] [Related]

  • 4. ICHD-3 is significantly more specific than ICHD-3 beta for diagnosis of migraine with aura and with typical aura.
    Göbel CH, Karstedt SC, Münte TF, Göbel H, Wolfrum S, Lebedeva ER, Olesen J, Royl G.
    J Headache Pain; 2020 Jan 07; 21(1):2. PubMed ID: 31910800
    [Abstract] [Full Text] [Related]

  • 5. Aura status: a not so frequent aura.
    João AA, Goucha TB, Martins IP.
    Cephalalgia; 2014 Dec 07; 34(14):1150-62. PubMed ID: 24740515
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Migrainous aura subtypes in hospitalized children].
    Biedroń A, Steczkowska M, Zajac A, Stolarska U, Kroczka S.
    Przegl Lek; 2009 Dec 07; 66(11):952-7. PubMed ID: 20297637
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Implications of clinical subtypes of migraine with aura.
    Eriksen MK, Thomsen LL, Olesen J.
    Headache; 2006 Feb 07; 46(2):286-97. PubMed ID: 16492238
    [Abstract] [Full Text] [Related]

  • 13. Application of ICHD-II criteria for headaches in a TMJ and orofacial pain clinic.
    Kang JK, Ryu JW, Choi JH, Merrill RL, Kim ST.
    Cephalalgia; 2010 Jan 07; 30(1):37-41. PubMed ID: 19438924
    [Abstract] [Full Text] [Related]

  • 14. Polygenic risk provides biological validity for the ICHD-3 criteria among Finnish migraine families.
    Häppölä P, Gormley P, Nuottamo ME, Artto V, Sumelahti ML, Nissilä M, Keski-Säntti P, Ilmavirta M, Kaunisto MA, Hämäläinen EI, Ripatti S, Pirinen M, Wessman M, Palotie A, Kallela M, International Headache Genetics Consortium (IHGC).
    Cephalalgia; 2022 Apr 07; 42(4-5):345-356. PubMed ID: 34648375
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Migraine without aura.
    Paemeleire K, Vandenbussche N, Stark R.
    Handb Clin Neurol; 2023 Apr 07; 198():151-167. PubMed ID: 38043959
    [Abstract] [Full Text] [Related]

  • 17. Explicit diagnostic criteria for transient ischemic attacks to differentiate it from migraine with aura.
    Lebedeva ER, Gurary NM, Gilev DV, Christensen AF, Olesen J.
    Cephalalgia; 2018 Jul 07; 38(8):1463-1470. PubMed ID: 28994605
    [Abstract] [Full Text] [Related]

  • 18. Visual symptoms and childhood migraine: Qualitative analysis of duration, location, spread, mobility, colour and pattern.
    Ahmed M, Boyd C, Vavilikolanu R, Rafique B.
    Cephalalgia; 2018 Dec 07; 38(14):2017-2025. PubMed ID: 29629600
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.